000520 — Samil Pharmaceutical Co Cashflow Statement
0.000.00%
- KR₩170bn
- KR₩323bn
- KR₩196bn
- 15
- 55
- 14
- 14
Annual cashflow statement for Samil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 786 | 1,341 | -5,347 | -28.3 | 1,664 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 7,422 | 9,782 | 9,678 | 8,806 | 7,734 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,633 | -7,547 | -7,626 | -9,613 | -2,599 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 10,590 | 7,775 | 1,417 | 4,154 | 11,746 |
Capital Expenditures | -14,481 | -17,211 | -33,091 | -48,656 | -24,391 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -11,571 | 12,622 | -12,217 | 12,720 | 4,613 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -26,052 | -4,589 | -45,308 | -35,936 | -19,778 |
Financing Cash Flow Items | -2,284 | -1,969 | -1,893 | -1,877 | -7,603 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 29,064 | -3,323 | 31,874 | 29,706 | 8,483 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 13,729 | -721 | -12,005 | -2,089 | -997 |